Title : The discovery and development of transmembrane serine protease 2 (TMPRSS2) inhibitors as candidate drugs for the treatment of COVID-19.

Pub. Date : 2022 Mar

PMID : 35072549






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Two known TMPRSS2 inhibitors, namely camostat and nafamostat, approved drugs for the treatment of pancreatitis, are under clinical trials as potential drugs against COVID-19. nafamostat transmembrane serine protease 2 Homo sapiens